Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial

BMJ (Online)

Volumn 339, Issue 7721, 2009, Pages 613-615

  Bijkerk, C J ^a   De Wit, N J ^a   Muris, J W M ^b   Whorwell, P J ^c   Knottnerus, J A ^b   Hoes, A W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISPAGULA; PLACEBO;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DIET THERAPY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; FIBER; GENERAL PRACTICE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RICE BRAN; SOLUBILITY; TREATMENT DURATION;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; DIETARY FIBER; FAMILY PRACTICE; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PLANTAGO; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70349090574     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b3154     Document Type: Article

References (31)

1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130:1480-1491
2. Jones R. Treatment of irritable bowel syndrome in primary care. BMJ 2008;337:a2213.
3. Thompson WG, Heaton KW, Smyth GT, Smyth C. Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut 2000;46:78-82. (Pubitemid 30307681)
4. Ruigomez A, Wallander MA, Johansson S, Garcia Rodriguez LA. One-year follow-up of newly diagnosed irritable bowel syndrome patients. Aliment Pharmacol Ther 1999;13:1097-1102 (Pubitemid 29374112)
5. Mearin F, Badia X, Balboa A, Baro E, Caldwell E, Cucala M, et al. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol 2001;36:1155-1161 (Pubitemid 32917583)
6. Vandvik PO, Aabakken L, Farup PG. Diagnosing irritable bowel syndrome: poor agreement between general practitioners and the Rome II criteria. Scand J Gastroenterol 2004;39:448-453 (Pubitemid 38626624)
7. Janssen HA, Borghouts JA, Muris JW, Metsemakers JF, Koes BW, Knottnerus JA. Health status and management of chronic nonspecific abdominal complaints in general practice. Br J Gen Pract 2000;50:375-379
8. Oberndorff-Klein Woolthuis AH, Brummer RJ, de Wit NJ, Muris JW, Stockbrugger RW. Irritable bowel syndrome in general practice: an overview. Scand J Gastroenterol Suppl 2004;241:17-22. (Pubitemid 40051445)
9. Bijkerk CJ, de Wit NJ, StalmanWA, Knottnerus JA, Hoes AW, Muris JW. Irritable bowel syndrome in primary care: the patients' and doctors' views on symptoms, etiology and management. Can J Gastroenterol 2003;17:363-368
10. Miller V, Lea R, Agrawal A, Whorwell PJ. Bran and irritable bowel syndrome: the primary care perspective. Dig Liver Dis 2006;38:737-740 (Pubitemid 44356289)
11. Francis CY, Whorwell PJ. Bran and irritable bowel syndrome: time for reappraisal. Lancet 1994;344:39-40. (Pubitemid 24199426)
12. Bijkerk CJ, Muris JW, Knottnerus JA, Hoes AW, de Wit NJ. Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2004;19:245-251
13. Ford AC, Tally NJ, Spiegel BMR, Foxx-Orenstein AC, Schiller L, Quigley EMM, et al. Effect of fibre, antispasmodics and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ 2008;337:a2313.
14. Longstreth GF, Hawkey CJ, Mayer EA, Jones RH, Naesdal J, Wilson IK, et al. Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials. Aliment Pharmacol Ther 2001;15:959-964 (Pubitemid 32578967)
15. Van der Horst HE, van Dulmen AM, Schellevis FG, van Eijk JT, Fennis JF, Bleijenberg G. Do patients with irritable bowel syndrome in primary care really differ from outpatients with irritable bowel syndrome? Gut 1997;41:669-674
16. Classification Committee of WONCA. ICHPPC-2 defined: international classification of health problems in primary care. Oxford: Oxford University Press, 1983.
17. Boukes FS, van der Horst HE, Assendelft WJ. [Summary of the Dutch College of General Practitioners' "irritable bowel syndrome" standard.] Ned Tijdschr Geneeskd 2002;146:799-802.
18. Van Staveren WA, Hautvast JG, Katan MB, Van Montfort MA, Van Oosten-Van Der Goes HG. Dietary fibre consumption in an adult Dutch population. J Am Diet Assoc 1982;80:324-330
19. Bijkerk CJ, de Wit NJ, Muris JW, Jones RH, Knottnerus JA, Hoes AW. Outcome measures in irritable bowel syndrome: comparison of psychometric and methodological characteristics. Am J Gastroenterol 2003;98:122-127
20. Irvine EJ, Whitehead WE, Chey WD, Matsueda K, Shaw M, Talley NJ, et al. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology 2006;130:1538-1551
21. Mangel AW, Hahn BA, Heath AT, Northcutt AR, Kong S, Dukes GE, et al. Adequate relief as an endpoint in clinical trials in irritable bowel syndrome. J Int Med Res 1998;26:76-81. (Pubitemid 28211930)
22. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997;11:395-402. (Pubitemid 27183522)
23. Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci 1998;43:400-411 (Pubitemid 28124621)
24. Ocke MC, Bueno-de-Mesquita HB, Goddijn HE, Jansen A, Pols MA, Van Staveren WA, et al. The Dutch EPIC food frequency questionnaire. I. Description of the questionnaire, and relative validity and reproducibility for food groups. Int J Epidemiol 1997;26:S37-48.
25. Ocke MC, Bueno-de-Mesquita HB, Pols MA, Smit HA, Van Staveren WA, Kromhout D. The Dutch EPIC food frequency questionnaire. II. Relative validity and reproducibility for nutrients. Int J Epidemiol 1997;26:S49-58.
26. Bijkerk CJ, Muris JWM, Knottnerus JA, Hoes AW, de Wit NJ. Randomised patients in irritable bowel syndrome research had different disease characteristics compared to eligible unrecruited patients. J Clin Epidemiol 2008;11:1176-1181
27. Parisi G, Bottona E, Carrara M, Cardin F, Faedo A, Goldin D, et al. Treatment effects of partially hydrolyzed guar gumon symptoms and quality of life of patients with irritable bowel syndrome: a multicenter randomized open trial. Dig Dis Sci 2005;50:1107-1112 (Pubitemid 40864016)
28. Rees G, Davies J, Thompson R, Parker M, Liepins P. Randomised-controlled trial of a fibre supplement on the symptoms of irritable bowel syndrome. J R Soc Health 2005;125:30-34 (Pubitemid 40259814)
29. Snook J, Shepherd HA. Bran supplementation in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 1994;8:511-514 (Pubitemid 24324488)
30. Agrawal A, Whorwell PJ. Irritable bowel syndrome: diagnosis and management. BMJ 2006;332:280-283 (Pubitemid 43235341)
31. Dalrymple J, Bullock I. Diagnosis and management of irritable bowel syndrome in adults in primary care: summary of the NICE guidance. BMJ 2008;336:556-558